Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: Utility of the health beliefs model

Multiple Sclerosis

Volumn 13, Issue 9, 2007, Pages 1146-1152

  Turner, Aaron P ^a,b,c,d   Kivlahan, D R ^a,c,d   Sloan, A P ^a,b   Haselkorn, J K ^a,b,d,e  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b VA Multiple Sclerosis Center of Excellence West

^c VA Center of Excellence in Substance Abuse Treatment and Education

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Health beliefs; Medication adherence; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; DEMOGRAPHY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEALTH BELIEF; HEALTH BELIEF MODEL; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIPLE SCLEROSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREDICTION; PRESCRIPTION; QUESTIONNAIRE; VETERAN; AGED; FOLLOW UP; GOVERNMENT; HEALTH BEHAVIOR; INFORMATION PROCESSING; MIDDLE AGED; MOTIVATION; OUTPATIENT; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; SELF CONCEPT; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MOTIVATION; MULTIPLE SCLEROSIS; OUTPATIENTS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; SELF EFFICACY; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 39549086423     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507078911     Document Type: Article

References (24)

1. Burks JS. A practical approach to immunomodulatory therapy for multiple sclerosis. Phys Med Rehabil Clin N Am 2005; 16: 449-66.
2. Mohr DC, Goodkin DE, Masuoka L, Dick LP, Russo D, Eckhardt J et al. Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. Multiple Sclerosis 1999; 5: 192-97.
3. Hadjimichael O, Volmer TL. Adherence to injection therapy in multiple sclerosis: Patients survey. Neurology 1999; 53: 1190-97.
4. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 13: 10-24.
5. Aiken LS, West SG, Woodward CK, Reno RR. Health beliefs and compliance with mammography-screening recommendations in asymptomatic women. Health Psychol 1994; 13: 122-29.
6. Arneson SW, Triplett JL, Hahnemann B. Merington E. Factors affecting parental use of child automobile safety restraints. Child Health Care 1985; 13: 181-86.
7. Cerkoney KA, Hart LK. The relationship between the Health Belief Model and compliance of persons with diabetes mellitus. Diabetes Care 1980; 3: 594-98.
8. Simonds JF, Goldstein D, Kilo C, Hoette S. The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psychol 1987; 55: 139-44.
9. Hershey JC, Morton BG, Davis JR, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980; 70: 1081-89.
10. Vollmer TL, Hadjimichael O, Preiningerova J, Ni W, Buenconsejo J. Disability and treatment patterns of multiple sclerosis patients in United States: A comparison of veterans and nonveterans. J Rehabil Res Dev 2002; 39: 163-74.
11. Beatty WW, Paul RH, Wilbanks SL, Hames KA, Blanco CR. Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment. Neurology 1995; 45: 718-23.
12. DiMatteo MR, Hays RD, Gritz ER, Roshan B. Patient adherence to cancer control regimens: Scale development and initial validation. Psychol Assess 1993; 5: 102-12.
13. Schwartz C, Vollmer TL, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 1999; 52: 63-70.
14. Heckman TG, Somlai AM, Peters J, Walker J, Otto-Salaj L, Galdabini CA et al. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care 1998; 10: 365-75.
15. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis 2001; 33: 865-72.
16. Haynes RB, McKibbon FA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1997; 348: 383-86.
17. Rogers PG, Bullman WR. Prescription medicine compliance: A review of the baseline of knowledge. A report of the National Council on Patient Information and Education. Journal or Pharmacoepidemiology 1995; 2: 3.
18. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care 1998; 36: 1138-61.
19. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
20. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. JAMA 2002; 288: 2880-83.
21. Mohr DC, Boudewyn AC, Likosky W. Levine E, Goodkin DE. Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Ann Behav Med 2001; 23: 125-32.
22. Fraser C, Hadjimichael O, Volmer TL. Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis. J Neurosci Nurs 2003; 35: 163-74.
23. Harrison JA, Mullen PD, Green LW. A meta-analysis of studies of the health belief model with adults. Health Educ Res 1992; 7: 107-16.
24. Tremlett HL, Oger JO. Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS. Neurology 2003; 61: 551-54.